New Robotic Microfluidic Platform Brings AI to Lipid Nanoparticle Design | Penn Engineering

New Robotic Microfluidic Platform Brings AI to Lipid Nanoparticle Design AI , Research and Innovation / March 9, 2026 Share: Author: Ian Scheffler AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases . But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery vehicles behind mRNA therapies like the COVID-19 vaccines,.